Back to search

Netherlands· NL-cf1b5f8ca13d

Sufentanil-hameln 50 microgram/ml oplossing voor injectie / infusie

A sufentanil product containing sufentanilcitraat, registered in Netherlands by hameln pharma gmbh. The same ATC class is registered in 11 of our 19 countries.

ATC N01AH03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSufentanil-hameln 50 microgram/ml opl…ATCN01AH03REGISTER NO.NL-cf1b5f8ca13dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Sufentanil is registered in 11 of 19 countries.

Countries holding a registration under ATC N01AH03 (sufentanil), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Sufentanil · ATC N01AH03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SUFENTANILCITRAAT
Manufacturer
hameln pharma gmbh
Country
Netherlands (NL)
ATC code
N01AH03
ATC class
Sufentanil
Defined daily dose
30 mcg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    26152

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for sufentanil.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sufentanil · interactions on record

216 records

  • 20 severe
  • 158 moderate
  • 38 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sufentanil in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sufentanil products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Sufenta, Sufentanil Hameln
  • Belgium · Sufenta, Sufenta Forte
  • Cyprus · Sofentil
  • Czechia · Sontilen, Sufenta
  • Germany · Sufenta, Sufenta Epidural
  • Denmark · Sofentil, Sufenta
  • Spain · Safentil, Secufen
  • Finland · Sufenta, Sufenta Forte
  • France · Sufenta, Sufentanil Renaudin
  • United Kingdom (Northern Ireland) · Dzuveo
  • Croatia · Sofentil, Sufentanil Altamedics
  • Hungary · Sufentanil Hameln, Sufentanil Torrex
  • Iceland · Dzuveo, Sufenta
  • Italy · Disufen, Sufentanil Hameln
  • Liechtenstein · Dzuveo, Sufenta
  • Luxembourg · Sufenta, Sufenta Forte
  • Latvia · Sontilen
  • Malta · Sofentil
  • Norway · Dzuveo, Sufenta
  • Poland · Sufentanil Chiesi, Sufentanil Hameln
  • Portugal · Sontilen, Sufenta
  • Romania · Sofentil
  • Sweden · Sufenta, Sufentanil Hameln
  • Slovenia · Sufentanil Hameln
  • Slovakia · Sofentil, Sufentanil Chiesi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b21feba9-b58a-4da9-a9be-df599e1a4f0e
GET /v1/drugs/b21feba9-b58a-4da9-a9be-df599e1a4f0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik, Epiduraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26152_smpc.pdf",
  "strength": null,
  "atc_label": "Sufentanil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26152",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "NATRIUMCHLORIDE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "SUFENTANILCITRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26152.pdf",
  "authorised_at": "2001/08/27",
  "procedure_number": "DE/H/0275/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "26152",
  "additional_monitoring": "N"
}

See everything about sufentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.